Effects of maternal captopril treatment during late pregnancy on neonatal lung development in rats

Regulatory Peptides

Volumn 177, Issue 1-3, 2012, Pages 97-106

  Capelari, Diego N ^a,b   Sánchez, Susana I ^b   Ortega, Hugo H ^c   Ciuffo, Gladys M ^a   Fuentes, Lucia B ^b  

^a Consejo Nacional de Investigaciones Científicas y Tecnológicas ^*  (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Angiotensin converting enzyme; Captopril; Cellular proliferation; Postnatal lung development; Pulmonary dysplasia; Renin angiotensin system

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CAPTOPRIL; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; LUNG ALVEOLUS CELL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROBLAST; LUNG INJURY; LUNG VOLUME; MYOFIBROBLAST; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; UPREGULATION; WESTERN BLOTTING;

ACTINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CAPTOPRIL; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; LUNG; MALE; MYOFIBROBLASTS; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; WEIGHT LOSS;

ANIMALIA; RATTUS;

EID: 84862771510     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.05.092     Document Type: Article

References (48)

1. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
2. Tufro-McReddie A., Gomez R.A. Ontogeny of the renin-angiotensin system. Semin Nephrol 1993, 13:519-530.
3. Lasaitiene D., Chen Y., Adams M.A., Friberg P. Further insights into the role of angiotensin II in kidney development. Clin Physiol Funct Imaging 2006, 26:197-204.
4. Sanchez S.I., Seltzer A.M., Fuentes L.B., Forneris M.L., Ciuffo G.M. Inhibition of angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol 2008, 588:114-123.
5. Sanchez S.I., Arce M.E., Fuentes L.B., Ciuffo G.M. Prenatal blockade of Ang II receptors affects neonatal rat hindbrain structure and receptor localization. Exp Neurol 2009, 220(2):246-254.
6. Corvol P., Williams T.A., Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol 1995, 248:283-305.
7. Tian X.L., Paul M. Species-specific splicing and expression of angiotensin converting enzyme. Biochem Pharmacol 2003, 66:1037-1044.
8. Buttar H.S. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997, 176:61-71.
9. Pryde P.G., Sedman A.B., Nugent C.E., Barr M. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993, 3:1575-1582.
10. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006, 82:23-28.
11. Cox R.M., Anderson J.M., Cox P. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy. BJOG 2003, 110:1038.
12. Nogueira-Silva C., Carvalho-Dias E., Piairo P., Nunes S., Baptista M.J., Moura R.S., Correia-Pinto J. Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia. Mol Med 2011, 18(1):231-243.
13. Bernstein K.E. Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension 2006, 47:509-514.
14. Kaparianos A., Argyropoulou E. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem 2011, 18:3506-3515.
15. Marshall R.P., Webb S., Bellingan G.J., Montgomery H.E., Chaudhari B., McAnulty R.J., Humphries S.E., Hill M.R., Laurent G.J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002, 166:646-650.
16. Yamazato Y., Ferreira A.J., Hong K.H., Sriramula S., Francis J., Yamazato M., Yuan L., Bradford C.N., Shenoy V., Oh S.P., Katovich M.J., Raizada M.K. Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer. Hypertension 2009, 54:365-371.
17. Stevenson K.M., Gibson K.J., Lumbers E.R. Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep. Br J Pharmacol 1995, 114:1495-1501.
18. Cooper W.O. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. J Cardiovasc Nurs 2008, 23:20-24.
19. Tabacova S., Little R., Tsong Y., Vega A., Kimmel C.A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003, 12:633-646.
20. Metzger R.J., Klein O.D., Martin G.R., Krasnow M.A. The branching programme of mouse lung development. Nature 2008, 453:745-750.
21. Burri P.H. Structural aspects of prenatal and postnatal development and growth of the lung 1997.
22. Chen H., Zhuang F., Liu Y.H., Xu B., Del Moral P., Deng W., Chai Y., Kolb M., Gauldie J., Warburton D., Moses H.L., Shi W. TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung. Eur Respir J 2008, 32:285-295.
23. Pua Z.J., Stonestreet B.S., Cullen A., Shahsafaei A., Sadowska G.B., Sunday M.E. Histochemical analyses of altered fetal lung development following single vs multiple courses of antenatal steroids. J Histochem Cytochem 2005, 53:1469-1479.
24. Lasaitiene D., Chen Y., Nannmark U., Wollmer P., Friberg P. Neonatal ACE inhibition in rats interferes with lung development. Clin Physiol Funct Imaging 2004, 24:65-68.
25. Bourbon J.R., Boucherat O., Boczkowski J., Crestani B., Delacourt C. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends Mol Med 2009, 15:169-179.
26. Bancalari E., Claure N., Sosenko I.R. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003, 8:63-71.
27. Morrell N.W., Grieshaber S.S., Danilov S.M., Majack R.A., Stenmark K.R. Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation. Am J Respir Cell Mol Biol 1996, 14:526-537.
28. Powell J.T., Whitney P.L. Postnatal development of rat lung. Changes in lung lectin, elastin, acetylcholinesterase and other enzymes. Biochem J 1980, 188:1-8.
29. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970, 26:57-60.
30. Murray B.A., Walsh D.J., FitzGerald R.J. Modification of the furanacryloyl-l-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. J Biochem Biophys Methods 2004, 59:127-137.
31. Manzur M.J., Muñoz R., Lucero A.A., Juri Ayub M., Alvarez S.E., Ciuffo G.M. Production of recombinant enzymes of wide use for research. Electron J Biotechnol 2006.
32. Terada Y., Tomita K., Nonoguchi H., Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 1993, 43:1251-1259.
33. Ruest L.B., Khalyfa A., Wang E. Development-dependent disappearance of caspase-3 in skeletal muscle is post-transcriptionally regulated. J Cell Biochem 2002, 86:21-28.
34. Adamson I.Y., King G.M. Sex differences in development of fetal rat lung. II. Quantitative morphology of epithelial-mesenchymal interactions. Lab Investig 1984, 50:461-468.
35. Ortega H.H., Salvetti N.R., Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction 2009, 137:865-877.
36. Yamada M., Kurihara H., Kinoshita K., Sakai T. Temporal expression of alpha-smooth muscle actin and drebrin in septal interstitial cells during alveolar maturation. J Histochem Cytochem 2005, 53:735-744.
37. Guron G., Molne J., Swerkersson S., Friberg P., Hansson S. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation. Nephrol Dial Transplant 2006, 21:522-525.
38. Kitterman J.A., Chapin C.J., Vanderbilt J.N., Porta N.F., Scavo L.M., Dobbs L.G., Ertsey R., Goerke J. Effects of oligohydramnios on lung growth and maturation in the fetal rat. Am J Physiol Lung Cell Mol Physiol 2002, 282:431-439.
39. Martinez L.A., Villalobos-Molina R. Early and chronic captopril or losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch Med Res 2003, 34:357-361.
40. Jugdutt B.I. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol 1995, 25:1718-1725.
41. Mecawi A.S., Araujo I.G., Fonseca F.V., Almeida-Pereira G., Cortes W.S., Rocha F.F., Reis L.C. Behavioural changes induced by angiotensin-converting enzyme inhibition during pregnancy and lactation in adult offspring rats. Clin Exp Pharmacol Physiol 2009, 36:495-500.
42. Takeda-Matsubara Y., Iwai M., Cui T.X., Shiuchi T., Liu H.W., Okumura M., Ito M., Horiuchi M. Roles of angiotensin type 1 and 2 receptors in pregnancy-associated blood pressure change. Am J Hypertens 2004, 17:684-689.
43. Lassegue B., Alexander R.W., Nickenig G., Clark M., Murphy T.J., Griendling K.K. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol 1995, 48:601-609.
44. Shanmugam S., Corvol P., Gasc J.M. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 1996, 28:91-97.
45. Rosenfeld C.R., Zagariya A.M., Liu X.T., Willis B.C., Fluharty S., Vidyasagar D. Meconium increases type 1 angiotensin II receptor expression and alveolar cell death. Pediatr Res 2008, 63:251-256.
46. Mitchell J.J., Reynolds S.E., Leslie K.O., Low R.B., Woodcock-Mitchell J. Smooth muscle cell markers in developing rat lung. Am J Respir Cell Mol Biol 1990, 3:515-523.
47. Rishikof D.C., Lucey E.C., Kuang P.P., Snider G.L., Goldstein R.H. Induction of the myofibroblast phenotype following elastolytic injury to mouse lung. Histochem Cell Biol 2006, 125:527-534.
48. Long X., Xiong S.D., Xiong W.N., Xu Y.J., Zhang Z.X., Cao Y., Chen J., Xu X.H. Losartan inhibited angiotensin induced human lung fibroblast transformation and collagen synthesis. Zhonghua Jie He He Hu Xi Za Zhi 2007, 30(4):273-278.